Onabotulinumtoxin A for Treating Overactive/Poor Compliant Bladders in Children and Adolescents with Neurogenic Bladder Secondary to Myelomeningocele

Author： Marte Antonio

Publisher： MDPI

E-ISSN： 2072-6651|5|1|16-24

ISSN： 2072-6651

Source： Toxins, Vol.5, Iss.1, 2012-12, pp. : 16-24

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Patients with Frailty, Medical Comorbidities or Prior Lower Urinary Tract Surgery

By Liao Chun-Hou Wang Chung-Cheng Jiang Yuan-Hong

Toxins, Vol. 8, Iss. 4, 2016-03 ,pp. : 91-91

MDPI

Access to resources Recommend Favorite

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?

By Kuo Yuh-Chen Kuo Hann-Chorng

Toxins, Vol. 8, Iss. 3, 2016-03 ,pp. : 75-75

MDPI

Access to resources Recommend Favorite

Botulinum toxin A for the Treatment of Overactive Bladder

By Hsieh Po-Fan Chiu Hung-Chieh Chen Kuan-Chieh Chang Chao-Hsiang Chou Eric Chieh-Lung

Toxins, Vol. 8, Iss. 3, 2016-02 ,pp. : 59-59

MDPI

Access to resources Recommend Favorite

Evaluation and Management of Neurogenic Bladder: What Is New in China?

By Liao Limin

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 18580-18600

MDPI

Access to resources Recommend Favorite

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder

By Rajabalaya Rajan Leen Guok Chellian Jestin Chakravarthi Srikumar David Sheba R.

Pharmaceutics, Vol. 8, Iss. 3, 2016-08 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite